These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1221433)

  • 1. Preparation and evaluation of a sustained naloxone delivery system in rats.
    Fishman J; Hahn EF; Norton BI; Ronai A; Foldes FF
    Pharmacology; 1975; 13(6):513-9. PubMed ID: 1221433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone.
    Yeung JC; Rudy TA
    J Pharmacol Exp Ther; 1980 Dec; 215(3):626-32. PubMed ID: 7441522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone blockade of morphine analgesia: a dose-effect study of duration and magnitude.
    Markowitz R; Jacobson J; Bain G; Kornetsky C
    J Pharmacol Exp Ther; 1976 Nov; 199(2):385-8. PubMed ID: 978492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the efficacy of naloxone induced by stress, cyclic adenosine monophosphate, and morphine tolerance.
    Harris RA; Loh HH; Way EL
    Eur J Pharmacol; 1976 Sep; 39(1):1-10. PubMed ID: 183962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats.
    Gabriel SM; Simpkins JW
    Neuroendocrinology; 1983 Nov; 37(5):342-8. PubMed ID: 6139759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved long-acting delivery system for narcotic antagonists.
    Misra AL; Pontani RB
    NIDA Res Monogr; 1981; 28():254-64. PubMed ID: 6791009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
    Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
    Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.
    Boban Blagaic A; Turcic P; Blagaic V; Dubovecak M; Jelovac N; Zemba M; Radic B; Becejac T; Stancic Rokotov D; Sikiric P
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():177-81. PubMed ID: 20388962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the rat.
    Porreca F; Cowan A; Tallarida RJ
    Eur J Pharmacol; 1981 Nov; 76(1):55-9. PubMed ID: 7318922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance.
    Harris RA; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):488-98. PubMed ID: 1195132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.
    Tallarida RJ; Harakal C; Maslow J; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):38-45. PubMed ID: 660555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.